Runway Growth Finance Corp.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Control and Affiliate Investments
The Company classifies its investment portfolio by level of affiliation and control in accordance with the requirements of the 1940 Act. As defined in the 1940 Act, investee companies are deemed as affiliated investments when a company or individual possesses, or has the right to acquire within 60 days or less, beneficial ownership of 5.0% or more of the outstanding voting securities of an investee company. Control investments are those where the investor has the ability or power to exercise a controlling influence over the management or policies of an investee company. Control is generally deemed to exist when a company or individual possesses, or has the right to acquire within 60 days or less, beneficial ownership of more than 25.0% of the outstanding voting securities of an investee company, or maintains greater than 50.0% representation on the investee company's board of directors.
The Company’s affiliate and control investments as of December 31, 2025, along with the transactions during the year ended December 31, 2025, are as follows (in thousands):
| Portfolio Company · Investment Description · Investment Income Earned 2025 · Fair Value as of December 31, 2024 · Gross Additions(1) · Gross Reductions(2) · Net Realized Gain (Loss) · Net Change in Unrealized Gain (Loss) · Fair Value as of December 31, 2025(3) | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Affiliate Investments | ||||||||||||||||||||||||
| Debt Investments | ||||||||||||||||||||||||
| Gynesonics, Inc. -Senior Secured | SOFR+8.75%, 8.00% ceiling, 5.00% ETP, due 11/30/2026 | $ | 902 | $ | 27,217 | $ | - | $ | (26,235) | $ | - | $ | (982) | $ | - | |||||||||
| Total Debt Investments | 902 | 27,217 | - | (26,235) | - | (982) | - | |||||||||||||||||
| Equity Investments | ||||||||||||||||||||||||
| Coginiti Corp · Common Stock · - · - · - · - · - · - · - | ||||||||||||||||||||||||
| Gynesonics, Inc. | Series A-2 Preferred Stock | - | 25,000 | - | (25,000) | - | - | - | ||||||||||||||||
| Series A-1 Preferred Stock | - | 12,355 | - | (12,355) | 9,255 | (9,255) | - | |||||||||||||||||
| Total Equity Investments | - | 37,355 | - | (37,355) | 9,255 | (9,255) | - | |||||||||||||||||
| Warrants | ||||||||||||||||||||||||
| Coginiti Corp · Common Stock · - · - · - · - · - · - · - | ||||||||||||||||||||||||
| Gynesonics, Inc. | Success fee | - | - | - | - | (312) | 312 | - | ||||||||||||||||
| Total Warrants | - | - | - | - | (312) | 312 | - | |||||||||||||||||
| Total Affiliate Investments | $ | 902 | $ | 64,572 | $ | - | $ | (63,590) | $ | 8,943 | $ | (9,925) | $ | - | ||||||||||
| Control Investments | ||||||||||||||||||||||||
| Equity Investments | ||||||||||||||||||||||||
| Pivot3, Inc. | 100% Equity Interest | - | 1,198 | - | - | - | 295 | 1,493 | ||||||||||||||||
| Runway-Cadma I LLC | 50% Equity Interest | - | 5,742 | 6,683 | - | - | 828 | 13,253 | ||||||||||||||||
| Total Equity Investments | - | 6,940 | 6,683 | - | - | 1,123 | 14,746 | |||||||||||||||||
| Total Control Investments | $ | - | $ | 6,940 | $ | 6,683 | $ | - | $ | - | $ | 1,123 | $ | 14,746 | ||||||||||
(1)
Gross additions include increases in the cost basis of investments resulting from fundings, PIK interest, accretion of OID and ETP, the exchange of one or more existing investments for one or more new investments and the movement of an investment between categories.
(2)
Gross reductions include decreases in the basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing investments for one or more new investments and the movement of an investment between categories.
(3)
All affiliate and control investments, which as of December 31, 2025 represented 3.04% ofthe Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors.
The Company’s affiliate and control investments as of December 31, 2024, along with the transactions during the year ended December 31, 2024, are as follows (in thousands):
| Portfolio Company · Investment Description · Investment Income Earned 2024 · Fair Value as of December 31, 2023 · Gross Additions(1) · Gross Reductions(2) · Net Realized Gain (Loss) · Net Change in Unrealized Gain (Loss) · Fair Value as of December 31, 2024(3) | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Affiliate Investments | ||||||||||||||||||||||||
| Debt Investments | ||||||||||||||||||||||||
| Gynesonics, Inc. -Senior Secured | SOFR+8.75%, 8.00% ceiling, 5.00% ETP, due 11/30/2026 | $ | 2,419 | $ | 23,586 | $ | 337 | $ | - | $ | - | $ | 3,294 | $ | 27,217 | |||||||||
| Total Debt Investments | 2,419 | 23,586 | 337 | - | - | 3,294 | 27,217 | |||||||||||||||||
| Equity Investments | ||||||||||||||||||||||||
| Coginiti Corp | Common Stock | - | 856 | - | - | - | (856) | - | ||||||||||||||||
| Gynesonics, Inc. | Series A-2 Preferred Stock | - | 21,461 | - | - | - | 3,539 | 25,000 | ||||||||||||||||
| Series A-1 Preferred Stock | - | 4,577 | - | - | - | 7,778 | 12,355 | |||||||||||||||||
| Total Equity Investments | - | 26,894 | - | - | - | 10,461 | 37,355 | |||||||||||||||||
| Warrants | ||||||||||||||||||||||||
| Coginiti Corp | Common Stock | - | 663 | - | - | - | (663) | - | ||||||||||||||||
| Gynesonics, Inc. | Success fee | - | 313 | - | - | - | (313) | - | ||||||||||||||||
| Total Warrants | - | 976 | - | - | - | (976) | - | |||||||||||||||||
| Total Affiliate Investments | $ | 2,419 | $ | 51,456 | $ | 337 | $ | - | $ | - | $ | 12,779 | $ | 64,572 | ||||||||||
| Control Investments | ||||||||||||||||||||||||
| Equity Investments | ||||||||||||||||||||||||
| Pivot3, Inc. | 100% Equity Interest | - | 950 | - | - | - | 248 | 1,198 | ||||||||||||||||
| Runway-Cadma I LLC | 50% Equity Interest | - | - | 5,600 | - | - | 142 | 5,742 | ||||||||||||||||
| Total Equity Investments | - | 950 | 5,600 | - | - | 390 | 6,940 | |||||||||||||||||
| Total Control Investments | $ | - | $ | 950 | $ | 5,600 | $ | - | $ | - | $ | 390 | $ | 6,940 | ||||||||||
(1)
Gross additions include increases in the cost basis of investments resulting from fundings, PIK interest, accretion of OID and ETP, the exchange of one or more existing investments for one or more new investments and the movement of an investment between categories.
(2)
Gross reductions include decreases in the basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing investments for one or more new investments and the movement of an investment between categories.
(3)
All affiliate and control investments, which as of December 31, 2024 represented 13.90% of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors.
Portfolio Composition
The following table shows the fair value of the Company's portfolio of investments by geographic region as of December 31, 2025 and December 31, 2024 (in thousands):
| December 31, 2025 · December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Geographic Region · Investments at Fair Value · Percentage of Net Assets · Investments at Fair Value · Percentage of Net Assets | ||||||||
| United States | ||||||||
| Western United States | $ | 329,514 | 67.95 | % | $ | 431,567 | 83.83 | % |
| Northeastern United States | 171,308 | 35.32 | 264,780 | 51.43 | ||||
| Midwestern United States | 156,397 | 32.25 | 146,963 | 28.54 | ||||
| Northwestern United States | 74,198 | 15.30 | 72,414 | 14.06 | ||||
| South Central United States | 41,413 | 8.54 | 40,136 | 7.80 | ||||
| Southeastern United States | 21,590 | 4.45 | 20,932 | 4.07 | ||||
| Runway-Cadma I LLC(1) | 13,253 | 2.73 | 5,742 | 1.12 | ||||
| Total United States | 807,673 | 166.54 | 982,534 | 190.85 | ||||
| Germany | 67,665 | 13.95 | 34,163 | 6.64 | ||||
| United Kingdom | 34,415 | 7.10 | 28,360 | 5.51 | ||||
| Netherlands | 17,525 | 3.61 | 17,203 | 3.34 | ||||
| Canada | 124 | 0.03 | 14,580 | 2.83 | ||||
| Total | $ | 927,402 | 191.23 | % | $ | 1,076,840 | 209.17 | % |
(1)
Runway-Cadma I LLC is a joint venture between the Company and Cadma. This entity invests in secured loans to growth-stage companies that have been originated by the Company. See "Note 2 – Summary of Significant Accounting Policies" for further discussion.
Effective June 30, 2025, the Company transitioned from an internal industry classification system to the Global Industry Classification Standard ("GICS"). The following table shows the fair value of the Company's portfolio of investments by GICS industry as of December 31, 2025 (in thousands):
| Industry · Investments at Fair Value · Percentage of Net Assets | ||||
|---|---|---|---|---|
| Application Software | $ | 226,692 | 46.74 | % |
| Health Care Equipment & Services | 122,997 | 25.36 | ||
| Commercial & Professional Services | 115,268 | 23.77 | ||
| Systems Software | 97,823 | 20.17 | ||
| Financial Services | 83,915 | 17.31 | ||
| Technology Hardware & Equipment | 72,922 | 15.03 | ||
| Consumer Staples Distribution & Retail | 47,813 | 9.86 | ||
| Insurance | 44,831 | 9.25 | ||
| Household & Personal Products | 39,777 | 8.20 | ||
| Media & Entertainment | 30,297 | 6.25 | ||
| Multi-Sector Holdings(1) | 23,222 | 4.79 | ||
| Consumer Services | 19,851 | 4.09 | ||
| Pharmaceuticals, Biotechnology & Life Sciences | 1,994 | 0.41 | ||
| Total | $ | 927,402 | 191.23 | % |
(1)
Multi-Sector Holdings includes the Company's investment in Runway-Cadma I LLC, a joint venture between the Company and Cadma. This entity invests in secured loans to growth-stage companies that have been originated by the Company. See "Note 2 – Summary of Significant Accounting Policies" for further discussion.
The following table shows the fair value of the Company's portfolio of investments by industry as of December 31, 2024 (in thousands):
| Industry · Investments at Fair Value · Percentage of Net Assets | ||||
|---|---|---|---|---|
| Application Software | $ | 233,431 | 45.35 | % |
| Healthcare Technology | 218,688 | 42.48 | ||
| Internet Software and Services | 160,104 | 31.10 | ||
| Data Processing & Outsourced Services | 116,720 | 22.67 | ||
| System Software | 114,650 | 22.26 | ||
| Property & Casualty Insurance | 76,911 | 14.94 | ||
| Internet & Direct Marketing Retail | 50,729 | 9.86 | ||
| Human Resource & Employment Services | 40,560 | 7.88 | ||
| Electronic Equipment & Instruments | 40,354 | 7.84 | ||
| Healthcare Equipment | 15,382 | 2.98 | ||
| Multi-Sector Holdings(1) | 5,742 | 1.12 | ||
| Technology Hardware, Storage & Peripherals | 2,910 | 0.56 | ||
| Specialized Consumer Services | 365 | 0.07 | ||
| Advertising | 152 | 0.03 | ||
| Asset Management & Custody Banks | 138 | 0.03 | ||
| Biotechnology | 4 | - | ||
| Total | $ | 1,076,840 | 209.17 | % |
(1)
Multi-Sector Holdings includes the Company's investment in Runway-Cadma I LLC, a joint venture between the Company and Cadma. This entity invests in secured loans to growth-stage companies that have been originated by the Company. See "Note 2 – Summary of Significant Accounting Policies" for further discussion.
Derivative Financial Instruments
In the normal course of business, the Company may utilize derivative contracts in connection with its investment activities. Investments in derivative contracts are subject to additional risks that can result in a loss of all or part of an investment. The derivative activities and exposure to derivative contracts primarily involve equity price risks. In addition to the primary underlying risk, additional counterparty risk exists due to the potential inability of counterparties to meet the terms of their contracts.
Warrants provide exposure and potential gains upon increases in the portfolio company’s equity value. A warrant has a limited life and expires on a certain date. As a warrant’s expiration date approaches, the time value of the warrant will decline. In addition, if the stock underlying the warrant declines in price, the intrinsic value of an "in the money" warrant will decline. Further, if the price of the stock underlying the warrant does not exceed the strike price of the warrant on the expiration date, the warrant will expire worthless. As a result, there is the potential for the entire value of an investment in a warrant to be lost. The Company’s volume of warrant investment activity is closely correlated to its primary senior secured loans to portfolio companies. Counterparty risk exists from the potential failure of an issuer of warrants to settle its exercised warrants. The maximum risk of loss from counterparty risk is the fair value of the contracts and the purchase price of the warrants. The Board of Directors considers the effects of counterparty risk when determining the fair value of its investments in warrants.
For the year ended December 31, 2025, the Company had a net realized loss of$2.1 million and a net unrealized gain of$1.4 million from its investments in warrants. For the year ended December 31, 2024, the Company had a net realized gain of$1.6 million and a net unrealized loss of$2.6 million from its investments in warrants. For the year ended December 31, 2023, the Company had a net realized loss of $1.4 millionand a net unrealized loss of $5.2 million from its investments in warrants. Realized gains and losses from warrants are included in the respective control, affiliate, or non-control/non-affiliate "Net realized gain (loss)" on the Consolidated Statements of Operations. Unrealized gains and losses from investments in warrants are included in the respective control, affiliate, or non-control/non-affiliate "Net change in unrealized gain (loss)" on the Consolidated Statements of Operations.
The following table shows the Company's outstanding foreign currency forward contracts as of and for the year ended December 31, 2025 (in thousands):
| Foreign Currency · Counterparty · Maturity Date · Notional Amount to be Sold (£) · Notional Amount to be Purchased ($) · Unrealized Gain (Loss) ($) | ||||||
|---|---|---|---|---|---|---|
| British Pound Sterling (GBP) | Canadian Imperial Bank of Commerce | 5/14/2026 | 21,964 | 28,873 | (711) | |
| Total | $ | (711) | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.